Filter
256
Text search:
drug
dosing
Featured
Recommendations
35
New Publications
55
Language
Document type
No document type
136
Guidelines
58
Studies & Reports
30
Training Material
10
Manuals
6
Strategic & Response Plan
5
Fact sheets
4
Situation Updates
2
Resource Platforms
2
App
1
Infographics
1
Online Courses
1
Countries / Regions
India
12
South Africa
12
Kenya
9
Rwanda
9
Global
8
Tanzania
7
Ethiopia
6
Nigeria
5
Ghana
4
Uganda
4
Bangladesh
4
Western and Central Europe
4
Africa
4
USA
3
Sierra Leone
2
Zimbabwe
2
Philippines
2
South Sudan
2
Zambia
2
Syria
2
Cambodia
2
Malawi
2
Lesotho
2
Liberia
1
Congo, Democratic Republic of
1
Cameroon
1
Haiti
1
Nepal
1
Iraq
1
Germany
1
Sudan
1
Namibia
1
Ukraine
1
Myanmar / Burma
1
West and Central Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Tajikistan
1
Russia
1
Georgia
1
Authors & Publishers
Publication Years
Category
Countries
75
Clinical Guidelines
51
Women & Child Health
15
Capacity Building
11
Public Health
9
Key Resources
2
Annual Report MEDBOX
1
Pharmacy & Technologies
1
Toolboxes
HIV
38
TB
32
AMR
18
Pharmacy
16
Mental Health
11
NTDs
11
COVID-19
9
NCDs
9
Ebola & Marburg
5
Caregiver
5
Conflict
3
Refugee
3
Malaria
3
Polio
2
Specific Hazards
2
Cholera
1
Drug Distribution and Control: Preparation and Handling
This Technical Assistance Bulletin is intended to assist pharmacists in the extemporaneous compounding of non-sterile drug products for
...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organ
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the dru
...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been develop
...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone refere
...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment
...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support
...
Third edition
Explore best practise in pharmacy, and learn how to start a career as a pharmacist, with these online pharmacy courses from FutureLearn.
The key updates include: content update in various sections based on new evidence; design changes for enhanced usability; a streamlined and simplified clinical assessment that includes an algorithm for follow-up; inclusion of two new modules
- Essential Care and Practice that includes general guid
...
The manual is written for clinicians working at the district hospital (first-level referral care) who diagnose and manage sick adolescents and adults in resource constrained settings. It aims to support clinical reasoning, and to provide an effective clinical approach and protocols for the managemen
...
1PEP GUIDELINES | 2019 EDITION. The prevalence of both HIV and Hepatitis B is high in South Africa therefore there is a significant risk of acquiring these infections following exposure to infected material. Studies suggest that post- exposure prophylaxis (PEP) with highly active antiretroviral trea
...
